Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
publish chart | backtests Type: candle | line | advanced    Timeframe: intraday | daily | weekly | monthly  Settings
QCOR [NASD]
Questcor Pharmaceuticals, Inc.
Healthcare | Biotechnology | USA
financial highlights | statements
Index- P/E11.56 EPS (ttm)3.23 Insider Own0.75% Shs Outstand59.55M Perf Week2.22%
Market Cap2.22B Forward P/E7.98 EPS next Y4.68 Insider Trans-16.08% Shs Float58.46M Perf Month33.36%
Income198.20M PEG0.53 EPS next Q0.97 Inst Own- Short Float46.43% Perf Quarter31.48%
Sales548.45M P/S4.05 EPS this Y160.04% Inst Trans-2.15% Short Ratio13.38 Perf Half Y50.02%
Book/sh3.28 P/B11.38 EPS next Y18.48% ROA61.14% Target Price48.25 Perf Year-3.84%
Cash/sh2.58 P/C14.49 EPS next 5Y22.00% ROE92.23% 52W Range16.84 - 57.53 Perf YTD41.01%
Dividend1.00 P/FCF10.19 EPS past 5Y43.57% ROI81.61% 52W High-34.07% Beta0.77
Dividend %2.68% Quick Ratio2.38 Sales past 5Y59.22% Gross Margin92.85% 52W Low125.19% ATR2.00
Employees557 Current Ratio2.56 Sales Q/Q40.81% Oper. Margin54.25% RSI (14)60.66 Volatility8.67% 5.63%
OptionableYes Debt/Eq0.09 EPS Q/Q11.78% Profit Margin36.14% Rel Volume0.92 Prev Close37.34
ShortableYes LT Debt/Eq0.08 EarningsApr 30 AMC Payout19.32% Avg Volume2.03M Price37.93
Recom1.90 SMA2013.32% SMA5019.22% SMA20025.75% Volume959,518 Change1.58%
15-May-13Reiterated Mizuho Buy $41 → $50
01-May-13Reiterated Ladenburg Thalmann Buy $38 → $35
27-Feb-13Reiterated Ladenburg Thalmann Buy $33 → $38
21-Feb-13Upgrade Mizuho Neutral → Buy $28 → $41
30-Nov-12Initiated Mizuho Neutral $28
24-Oct-12Upgrade Ladenburg Thalmann Neutral → Buy $33
24-Sep-12Downgrade Ladenburg Thalmann Buy → Neutral
20-Sep-12Reiterated Oppenheimer Outperform $69 → $65
20-Sep-12Reiterated Ladenburg Thalmann Buy $57 → $45
18-Sep-12Reiterated Oppenheimer Outperform $59 → $69
11-Jun-12Reiterated Ladenburg Thalmann Buy $50 → $55
23-Feb-12Reiterated Ladenburg Thalmann Buy $46 → $49
08-Dec-11Reiterated Oppenheimer Outperform $45 → $53
05-Dec-11Initiated Ladenburg Thalmann Buy $51
26-Oct-11Reiterated Oppenheimer Outperform $35 → $45
25-Aug-11Reiterated Maxim Group Buy $32 → $37
27-Jul-11Reiterated Oppenheimer Outperform $27 → $35
27-Jul-11Reiterated Maxim Group Buy $28 → $32
13-May-11Reiterated Oppenheimer Outperform $23 → $27
13-May-11Reiterated Maxim Group Buy $24 → $28
19-May-13 11:35AM  Benjamin Graham's Rules For The Common Stock Component: Questcor Pharmaceuticals Inc. at Seeking Alpha
17-May-13 02:20PM  Outlook for the Most Shorted Stocks at Motley Fool
02:12PM  Analyst Favorites With Strong Buyback Activity: Questcor Pharmaceuticals Ranks As a Top Pick at Forbes
16-May-13 01:53PM  3 Value Investing Plays in Health Care at Motley Fool
01:29PM  Nasdaq stocks posting largest percentage decreases AP
10:07AM  EBay CTO Sells More Than 111K Shares and 4 Insider Sales to Note at Wall St. Cheat Sheet
15-May-13 06:02PM  Nasdaq stocks posting largest percentage decreases AP -9.46%
01:27PM  Nasdaq stocks posting largest percentage decreases AP
01:16PM  Wal-Mart Takes Up Safety Standards Solo, Broadcoms Dividend, and 3 More Hot Stocks at Wall St. Cheat Sheet
14-May-13 11:45PM  Questcor Pharmaceuticals' CEO Presents at Bank of America Merrill Lynch 2013 Health Care Conference (Transcript) at Seeking Alpha +13.07%
06:02PM  Nasdaq stocks posting largest percentage increases AP
04:10PM  Questcor Rises On Unusually High Volume (QCOR) at TheStreet
01:20PM  Questcor bears are running for cover optionMONSTER
13-May-13 11:08PM  QUESTCOR PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
02:43PM  10 Hot Healthcare Dogs Probe 6% To 38.2% Gains In April at Seeking Alpha
10-May-13 01:04PM  QUESTCOR PHARMACEUTICALS INC Financials EDGAR Online Financials +5.36%
10:41AM  Analysts Say These Dividend Stocks Are Undervalued at Seeking Alpha
09-May-13 10:43AM  Dividend Stocks On Sale As The Market Hits New Highs at Seeking Alpha +5.96%
08-May-13 06:18PM  Why Questcor Is Undervalued at Motley Fool
04:01PM  Questcor Pharmaceuticals to Present at Bank of America Merrill Lynch 2013 Healthcare Conference PR Newswire
07-May-13 04:19PM  Tesla CEO Talking With Google About Autopilot Systems at Bloomberg
06-May-13 08:01AM  QUESTCOR PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
12:33AM  Industry Ranks May 2013 at Seeking Alpha
04-May-13 11:30AM  3 Booming Biotech Companies at Motley Fool
03-May-13 06:03PM  Questcor Stock Delivers Big Growth And Income at Investor's Business Daily
05:45PM  The Nasdaq's 5 Most Hated Stocks at Motley Fool
02:37PM  Three "Buys" After Reporting Earnings on Wednesday at Motley Fool
02:35PM  Questcor Misses on Earnings, Revs Zacks
08:30AM  The Market's Got This Biotech All Wrong at Motley Fool
02-May-13 11:52AM  GARP Investing Blends Growth and Value Investment Strategies: Learn Which U.S. Stocks Display the Metrics to Qualify in this Portfolio-Construction Methodology in this Exclusive Money Manager Interview Wall Street Transcript +8.54%
08:32AM  QUESTCOR PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report EDGAR Online
01-May-13 09:19PM  Analysts: Cummins Should Be Bought On Weakness and 3 Other Research Notes to Read at Wall St. Cheat Sheet
08:28PM  Was Questcor's Q1 as Bad as It Looks? at Motley Fool
04:25PM  Questcor Rises On Unusually High Volume (QCOR) at TheStreet
11:15AM  Positive News in the Oncology Space Regarding Myeloma and Melanoma Drugs: Expert Analyst Boris Peaker Discusses Recent Successes for Biotechnology Companies Wall Street Transcript
10:12AM  Hedge Funds Are Buying These 3 Biotech Small Caps Trading Below Lowest Target Price at Seeking Alpha
09:21AM  Questcor Acthar sales still poised to grow, says Roth Capital theflyonthewall.com
30-Apr-13 07:05PM  Questcor Pharmaceuticals' CEO Discusses Q1 2013 Results - Earnings Call Transcript at Seeking Alpha
06:40PM  Questcor Pharmaceuticals Earnings:Heres Why the Stock is Falling Now at Wall St. Cheat Sheet
06:10PM  Radar Movers: Apples Latest Product is a Huge Hit, Facebook and BlackBerry Jump at Wall St. Cheat Sheet
05:54PM  Questor shares fall after hours on prescriptions AP
04:34PM  QCOR Crosses Above Key Moving Average Level at Forbes
04:21PM  Questcor 1st-qtr adjusted profit missed estimates at Reuters
04:09PM  InPlay: Questcor Pharma misses by $0.20, misses on revs Briefing.com
04:01PM  Questcor Reports First Quarter Financial Results PR Newswire
01:22PM  You Dont Have to Run a Cartel to Make Big Profits in Drugs at Motley Fool
12:52PM  You Dont Have to Run a Cartel to Make Big Profits in Drugs at Motley Fool
11:47AM  You Dont Have to Run a Cartel to Make Big Profits in Drugs at Motley Fool
11:22AM  Ian Somaiya, Managing Director and Senior Research Analyst at Piper Jaffray & Co., Interviews with The Wall Street Transcript: Identifying Hidden Value and Market Opportunities in Biotech Companies Wall Street Transcript
08:11AM  You Dont Have to Run a Cartel to Make Big Profits in Drugs at Motley Fool
07:07AM  Q1 2013 Questcor Pharmaceuticals, Inc. Earnings Release - After Market Close CCBN
29-Apr-13 04:16PM  You Dont Have to Run a Cartel to Make Big Profits in Drugs at Motley Fool
02:04PM  Questcor Pharmaceuticals Earnings Preview: Can This Streak Continue? at Wall St. Cheat Sheet
12:39PM  Questcor Pharmaceuticals In Play Ahead Of Earnings Release at Seeking Alpha
11:01AM  Wall Street Transcript Interview with Brian Skorney, Senior Analyst at Robert W. Baird & Co.: FDA Approvals Accelerate and Opportunities Arise in Hepatitis C Market Wall Street Transcript
26-Apr-13 02:29PM  [video] Earnings Parade Continues Next Week at TheStreet
11:42AM  Forbes Earnings Preview: Questcor Pharmaceuticals at Forbes
25-Apr-13 05:49PM  The 3 Drivers Behind The Big Pharma Rally at Seeking Alpha
03:21PM  Questcor Pharmaceuticals Stock Sees Short Interest Make 12.8% Move at TheStreet
12:51PM  Questcor Pharmaceuticals: How Can Such A Profitable Company Be So Risky? at Seeking Alpha
02:16AM  Questcor's Upcoming First Quarter Report: An Investor Reference Guide at Seeking Alpha
20-Apr-13 11:02AM  One Investor's Trash is Another Investor's Treasure at Motley Fool
18-Apr-13 05:02PM  Healthcare-Focused Hedgie Bullish on These Stocks at Motley Fool
17-Apr-13 10:25AM  Questcor Stock To Go Ex-dividend Tomorrow (QCOR) at TheStreet
10:00AM  DMLP, CBD, QCOR at TheStreet
16-Apr-13 10:40AM  Ex-Div Reminder for Questcor Pharmaceuticals at Forbes
10:04AM  Sarepta Is a Gamble Worth Taking at Motley Fool
15-Apr-13 07:31PM  Peter Lynch's GARP Stocks at Motley Fool
06:30AM  Questcor to Report First Quarter Results on April 30, 2013 PR Newswire
14-Apr-13 07:54AM  The Best- And Worst-Performing Biotech Stocks, April 5 To April 12 at Forbes
07:00AM  5 of Last Week's Biggest Losers at Motley Fool
12-Apr-13 04:23PM  3 Horrendous Health-Care Stocks This Week at Motley Fool
11:48AM  Dividend Channel Identifies Oversold Conditions For Top Ranked Dividend Stock QCOR at Forbes
11-Apr-13 08:57AM  X Factor: 5 Stocks Reaching Their Ex-Dividend Date on April 18 at Minyanville
09-Apr-13 06:01PM  Questcor Set To Beat Wall Street Predictions at Seeking Alpha
08-Apr-13 05:35PM  VIX - Options Volatility And Market Sonar: Monday Recap at Seeking Alpha
05:01PM  Questcor Pharmaceuticals Inc. (QCOR): Today's Featured Health Care Straggler at TheStreet
06-Apr-13 04:30PM  The Nasdaq's 5 Most Hated Stocks at Motley Fool
05-Apr-13 12:28PM  4 Stocks Undervalued By To Target Price With Short Covering at TheStreet
04-Apr-13 03:41PM  Questcor: More Focus On News, Less On Business? at Seeking Alpha
03-Apr-13 09:08AM  QUESTCOR PHARMACEUTICALS INC Files SEC form 8-K/A, Completion of Acquisition or Disposition of Assets EDGAR Online
01-Apr-13 05:23PM  AbbVie Offers Nice Dividend Yield, Stock At New High at Investor's Business Daily
28-Mar-13 04:07AM  S&P 1500 Most Heavily Shorted Stocks at Seeking Alpha
26-Mar-13 01:46PM  Quescor: Trading Based On Negative Speculations Rather Than Positive Financials at Seeking Alpha
12:00AM  Here's What This $4 Billion Winning Hedge Fund Company Has Bought and Sold at Motley Fool
25-Mar-13 11:54AM  Dendreon: Potentially Heading To $2/Share By 2016? at Seeking Alpha
09:45AM  UnitedHealth updates utilization review guidelines for Questcor's Acthar at theflyonthewall.com
09:35AM  InPlay: Questcor Pharma: UNH March update showing Acthar Gel is a proven treatment for West Syndrome and Multiple sclerosis Briefing.com
07:58AM  5 High Growth Dividend Stocks Worth Investigating at Seeking Alpha
22-Mar-13 11:30AM  Questcor Pharmaceuticals Breaks Below 200-Day Moving Average - Notable for QCOR at Forbes -7.49%
21-Mar-13 11:46AM  Questcor Presents Compelling Risk / Reward At $33 at Seeking Alpha
20-Mar-13 04:56PM  Questcor Pharmaceuticals Larger Than S&P 500 Component Advanced Micro Devices at Forbes
02:32PM  Acthar Gel Outperforms Methylprednisolone In Head-To-Head Study In MS Patients at Seeking Alpha
12:10PM  How Much Is Questcor Worth? at Seeking Alpha
14-Mar-13 10:59AM  Does Questcor's Dividend Have Room to Soar? at Motley Fool
13-Mar-13 01:29PM  2 Fallen Growth Stocks: 1 to Buy & 1 to Sell! at Motley Fool
11:20AM  Spectrum Pharmaceuticals: When Being "Long" Backfires! at Motley Fool
10:19AM  11.2% of DES Holdings Seeing Recent Insider Buys at Forbes
12-Mar-13 11:03AM  Analysts: Target Cuts Expenses and 3 New Opinions Investors Must Read at Wall St. Cheat Sheet
11-Mar-13 02:58PM  Expand Your Investing Horizons With These Three Options Strategies at Motley Fool
Questcor Pharmaceuticals, Inc., a biopharmaceutical company, provides drugs for the treatment of multiple sclerosis, nephrotic syndrome, and infantile spasms indications. It primarily offers H.P. Acthar Gel, an injectable drug for the treatment of acute exacerbations of multiple sclerosis in adults; to induce a diuresis or a remission of proteinuria in the nephrotic syndrome without uremia of the idiopathic type or that due to lupus erythematosus; and as monotherapy for the treatment of infantile spasms in infants and children under two years of age. The company’s H.P. Acthar Gel also focuses on rheumatology-related conditions, including collagen diseases and rheumatic disorders. In addition, it offers Doral for the treatment of insomnia. The company sells its Acthar primarily to specialty pharmacies; and Doral to pharmaceutical wholesalers. Questcor Pharmaceuticals, Inc. was founded in 1990 and is headquartered in Anaheim, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BAILEY DON MPresident and CEOMay 14Option Exercise5.09160,000814,400259,000May 15 08:08 PM
THOMPSON VIRGIL DDirectorMay 14Option Exercise4.755,00023,75030,000May 16 02:15 PM
THOMPSON VIRGIL DDirectorMay 14Sale37.465,000187,30025,000May 16 02:15 PM
BAILEY DON MPresident and CEOMay 14Sale40.58160,0006,492,06299,000May 15 08:08 PM
BAILEY DON MPresident and CEOMay 13Option Exercise5.0920,000101,800119,000May 15 08:08 PM
BAILEY DON MPresident and CEOMay 13Sale36.7020,000734,00099,000May 15 08:08 PM
THOMPSON VIRGIL DDirectorMay 09Option Exercise4.752,18710,38827,187May 13 08:11 PM
THOMPSON VIRGIL DDirectorMay 09Sale35.002,18776,54525,000May 13 08:11 PM
BAILEY DON MPresident and CEOApr 25Option Exercise5.0910,03151,058109,031Apr 26 05:34 PM
BAILEY DON MPresident and CEOApr 25Sale30.0610,031301,57299,000Apr 26 05:34 PM
BAILEY DON MPresident and CEOApr 24Option Exercise5.099,96950,742108,969Apr 26 05:34 PM
BAILEY DON MPresident and CEOApr 24Sale30.009,969299,10299,000Apr 26 05:34 PM
THOMPSON VIRGIL DDirectorMar 21Option Exercise3.7642,500159,77572,500Mar 25 08:25 PM
THOMPSON VIRGIL DDirectorMar 21Sale35.0047,5001,662,50025,000Mar 25 08:25 PM
BAILEY DON MPresident and CEOMar 13Option Exercise5.0920,000101,800119,000Mar 15 08:24 PM
BAILEY DON MPresident and CEOMar 13Sale32.0620,000641,26099,000Mar 15 08:24 PM
BAILEY DON MPresident & CEOFeb 19Option Exercise5.0935,600181,204134,600Feb 20 07:28 PM
BAILEY DON MPresident & CEOFeb 19Sale30.1335,6001,072,56499,000Feb 20 07:28 PM
BAILEY DON MPresident & CEOFeb 15Option Exercise5.094,40022,396103,400Feb 20 07:28 PM
BAILEY DON MPresident & CEOFeb 15Sale30.004,400132,00099,000Feb 20 07:28 PM
BAILEY DON MPresident & CEODec 19Option Exercise5.0960,000305,400159,000Dec 21 07:14 PM
BAILEY DON MPresident & CEODec 19Sale30.1560,0001,809,11299,000Dec 21 07:14 PM
Medeiros David JeffreyEVP and CTONov 05Buy23.9445,0001,077,40063,028Nov 06 04:39 PM
Medeiros David JeffreyEVP and CTONov 02Buy23.8010,000238,00018,028Nov 06 04:39 PM
Cartt Stephen LaHueExecutive VP & CBONov 02Buy24.1710,000241,69688,198Nov 06 04:39 PM
THOMPSON VIRGIL DDirectorOct 11Option Exercise4.9415,00074,02530,000Oct 15 06:22 PM
FARRELL STEPHEN CDirectorOct 11Option Exercise4.757,50035,62516,250Oct 15 06:22 PM
BLUTT MITCHELL J MDDirectorSep 04Option Exercise12.5714,730185,12914,730Sep 06 04:58 PM
BLUTT MITCHELL J MDDirectorSep 04Sale47.6010,000476,000220,000Sep 06 04:58 PM
BLUTT MITCHELL J MDDirectorSep 04Sale47.6014,730701,1480Sep 06 04:58 PM
BAILEY DON MPresident & CEOAug 27Option Exercise5.0940,000203,600139,000Aug 28 07:15 PM
BAILEY DON MPresident & CEOAug 27Sale43.0740,0001,722,73699,000Aug 28 07:15 PM
Young DavidChief Scientific OfficerAug 10Option Exercise4.3610,62546,31913,903Aug 14 03:58 PM
FARRELL STEPHEN CDirectorJul 27Option Exercise4.458,75038,9388,750Jul 31 01:06 PM
BAILEY DON MPresident & CEOJul 10Option Exercise4.5730,000137,174129,000Jul 12 05:00 PM
BAILEY DON MPresident & CEOJul 10Sale57.6830,0001,730,37799,000Jul 12 05:00 PM
BLUTT MITCHELL J MDDirectorJul 02Sale53.1170,0003,717,980230,000Jul 05 01:21 PM
BAILEY DON MPresident & CEOJun 11Option Exercise0.4430,00013,200129,000Jun 13 12:55 PM
BAILEY DON MPresident & CEOJun 11Sale45.3730,0001,361,14599,000Jun 13 12:55 PM
Mulroy Michael H.Sr VP, CFO & General CounselMay 23Buy40.001,00040,0002,117May 24 09:01 AM
open in yahoo | open in reuters | open in google